Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market, announces that it has engaged the corporate communications expertise of CryptoCurrencyWire (“CCW”).
“Our award-winning proprietary technology is being installed in some of the top research laboratories around the world, we have just gone from one to six sales personnel, we will finish the development and release four new instruments to the market over the next 18 months, and our revenue continues to grow year-over-year. We believe that we now have the right resources, tools, and people to accelerate our growth plan and capture an even greater share of this large and expanding biopharma market,” said Richard T. Schumacher, President and CEO of Pressure BioSciences. “We look forward to integrating CryptoCurrencyWire’s strategies into our own as we focus on delivering an equitable return to our shareholders by increasing the exposure of our company and its potentially remarkable impact on the life sciences industry.”
CCW is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. CCW’s strategies help public and private organizations find their voice and build market visibility. As part of the Client-Partner relationship with Pressure BioSciences, CCW will leverage its investor-based distribution network of over 5,000 key syndication outlets, various newsletters, social media channels, blogs, and other outreach tools to generate greater brand awareness for the Company.
“Pressure BioSciences has developed a cutting-edge technology that has the potential to play a significant role in a number of commercially important areas,” states Sherri Franklin, director of Content Marketing for CCW. “We look forward to assisting the company with a corporate communications campaign that effectively keeps shareholders and the investment community up-to-date on its operations, growth, and unique technology acceptance.”
For more information, visit the company’s website at www.PressureBiosciences.com
More from CryptoCurrencyWire
About CryptoCurrencyWire
CryptoCurrencyWire (CCW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CryptoNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CCW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness. CCW is where news, content and information converge.
For more information please visit https://www.cryptocurrencywire.com
Please see full terms of use and disclaimers on the CryptoCurrencyWire website applicable to all content provided by CCW, wherever published or re-published: https://www.cryptocurrencywire.com/disclaimer/
CryptoCurrencyWire (CCW)
New York, New York
www.cryptocurrencywire.com
212.994.9818 Office
Editor@CryptoCurrencyWire.com
